comparing liraglutide 1.2 mg/day + metformin 1000 mg BID with liraglutide 3 mg/day, the combination therapy was effective in reducing fasting glucose and insulin, HOMA-IR, and LDL cholesterol, while only the high dose of liraglutide resulted in a significant improvement of 120 min during OGTT glucose and insulin levels along with a higher weight loss [63]
Indications (Research Use Only) As research protocols show, Retatrutide is being studied for the following potential indications: Obesity management: One of the primary areas of investigation is the treatment of obesity, particularly in individuals with a body mass index (BMI) above clinical thresholds that do not acquire substantial results through healthy diet or sport
Most Affordable Providers Based on Commitment Length Many providers offer significant discounts when you sign up for longer monthly commitments
This product is not approved for human or veterinary consumption
Keeping a food diary for two to three weeks can help identify specific triggers, as individual tolerance varies
NASH, Nonalcoholic steatohepatitis
